Heritability of MRI Lesion Volume in CADASIL Evidence for Genetic Modifiers

Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3 . However, little is known about the factor...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 37; no. 11; pp. 2684 - 2689
Main Authors Opherk, Christian, Peters, Nils, Holtmannspötter, Markus, Gschwendtner, Andreas, Müller-Myhsok, Bertram, Dichgans, Martin
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.11.2006
Subjects
Online AccessGet full text
ISSN0039-2499
1524-4628
1524-4628
DOI10.1161/01.STR.0000245084.35575.66

Cover

Loading…
Abstract Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3 . However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. Methods— One hundred and fifty-one affected individuals (mean age±SD=45.7±10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. Results— In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P <0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=±0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE±0.255). Conclusions— Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.
AbstractList The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. One hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255). Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.
BACKGROUND: and Purpose- The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. METHODS: One hundred and fifty-one affected individuals (mean age plus or minus SD=45.7 plus or minus 10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. RESULTS: In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE= plus or minus 0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE plus or minus 0.255). CONCLUSIONS: Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.
Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3 . However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions. Methods— One hundred and fifty-one affected individuals (mean age±SD=45.7±10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates. Results— In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P <0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=±0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE±0.255). Conclusions— Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.
The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.BACKGROUND AND PURPOSEThe phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), a small vessel disease caused by mutations in NOTCH3. However, little is known about the factors that underlie this variability. We sought to quantify the contribution of modifying genetic effects to individual differences in the volume of cerebral ischemic lesions.One hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.METHODSOne hundred and fifty-one affected individuals (mean age+/-SD=45.7+/-10.4) from 95 unrelated families with CADASIL underwent MRI. The volume of lesions visible on T2-weighted images and the intracranial volume (ICV) were quantified and vascular risk factors were assessed. Because of a skewed distribution, lesion volume measures were square-root transformed. Variance component methods were used to estimate the heritability of lesion volumes (ie, the proportion of variation caused by additive genetic factors) after adjusting for covariates.In multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255).RESULTSIn multivariate analyses, higher age, a larger ICV, and a higher diastolic blood pressure were independently associated with a larger volume of T2-visible lesions (all P<0.05). After adjustment for age the point estimate for the heritability of the square-root-transformed measure of T2 lesion volume was 0.634 (SE=+/-0.286). Adjustment for age, sex, ICV, and diastolic blood pressure increased the estimated heritability to 0.738 (SE+/-0.255).Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.CONCLUSIONSHeritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. These findings justify a systematic search for genetic variants that modify disease progression.
Author Peters, Nils
Opherk, Christian
Müller-Myhsok, Bertram
Gschwendtner, Andreas
Holtmannspötter, Markus
Dichgans, Martin
Author_xml – sequence: 1
  givenname: Christian
  surname: Opherk
  fullname: Opherk, Christian
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
– sequence: 2
  givenname: Nils
  surname: Peters
  fullname: Peters, Nils
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
– sequence: 3
  givenname: Markus
  surname: Holtmannspötter
  fullname: Holtmannspötter, Markus
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
– sequence: 4
  givenname: Andreas
  surname: Gschwendtner
  fullname: Gschwendtner, Andreas
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
– sequence: 5
  givenname: Bertram
  surname: Müller-Myhsok
  fullname: Müller-Myhsok, Bertram
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
– sequence: 6
  givenname: Martin
  surname: Dichgans
  fullname: Dichgans, Martin
  organization: From the Neurologische Klinik (C.O., N.P., A.G., M.D.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; the Abteilung für Neuroradiologie (M.H.), Klinikum Grosshadern, Ludwig-Maximilians-Universität, München, Germany; and the Max Planck Institut für Psychiatrie (B.M.-M.), München, Germany
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18266901$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17008614$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtPwzAQhC0EgvL4CyhCghMJXmftOJyoyqtSEVILXC3HcSSjPEqcHPrvSaFQiQt72cu3M6uZQ7JbN7Ul5AxoBCDgikK0eJlHdBiGnEqMYs4THgmxQ0bAGYYomNwlI0rjNGSYpgfk0Pv3NR9Lvk8OIKFUCsARuXy0ret05krXrYKmCJ7m02BmvWvq4K0p-8oGrg4m49vxYjo7JnuFLr092ewj8np_9zJ5DGfPD9PJeBYaBN6FhtoMDUgpIcvjVIAGHNxybRGlZELoBI1INLUosEh4lgNiYiyjzMTIZHxELr51l23z0Vvfqcp5Y8tS17bpvRIpZSAo_xeENOZpItaKpxuwzyqbq2XrKt2u1E8QA3C-AbQ3uixaXRvnt9z67ZTCwN18c6ZtvG9tocwQXzfE1bXalQqoWnekKKihI7XtSH11pIQYJK7_SPy6_H_8CVczkag
CODEN SJCCA7
CitedBy_id crossref_primary_10_1016_j_jns_2016_05_061
crossref_primary_10_1007_s12975_010_0041_5
crossref_primary_10_1161_CIRCRESAHA_122_319950
crossref_primary_10_1007_s00415_009_5048_z
crossref_primary_10_1016_j_neulet_2009_06_087
crossref_primary_10_1016_j_neurobiolaging_2014_08_021
crossref_primary_10_1212_WNL_0000000000002263
crossref_primary_10_1016_S1474_4422_07_70028_5
crossref_primary_10_1097_YCO_0b013e3282f945d5
crossref_primary_10_4199_C00052ED1V01Y201204GMM001
crossref_primary_10_1007_s00108_009_2469_9
crossref_primary_10_1161_STROKEAHA_122_039325
crossref_primary_10_1038_jcbfm_2015_71
crossref_primary_10_1212_01_wnl_0000339038_65508_96
crossref_primary_10_1016_j_neurobiolaging_2022_11_013
crossref_primary_10_1007_s00415_015_7794_4
crossref_primary_10_1055_s_0043_1769618
crossref_primary_10_1136_jnnp_2020_325838
crossref_primary_10_1161_STROKEAHA_114_006849
crossref_primary_10_1111_j_1468_2982_2009_01940_x
crossref_primary_10_1111_j_1552_6569_2008_00336_x
crossref_primary_10_1093_hmg_ddr345
crossref_primary_10_1001_jamaneurol_2022_3832
crossref_primary_10_1212_WNL_0000000000200744
crossref_primary_10_1016_j_jpsychires_2010_04_019
crossref_primary_10_1111_j_1755_5949_2010_00181_x
crossref_primary_10_1001_jamaneurol_2022_3994
crossref_primary_10_1093_hmg_ddz285
crossref_primary_10_1161_JAHA_123_035771
crossref_primary_10_1212_01_CON_0000396959_52198_1b
crossref_primary_10_1111_head_12169
crossref_primary_10_1186_s12916_017_0778_8
crossref_primary_10_1192_apt_bp_107_004655
crossref_primary_10_1371_journal_pmed_1000225
crossref_primary_10_1177_0333102410384637
crossref_primary_10_1111_ane_12400
crossref_primary_10_1007_s12035_018_1055_3
crossref_primary_10_1016_j_ebiom_2024_105297
Cites_doi 10.1093/brain/114.2.761
10.1007/s004150050083
10.1161/01.str.0000196987.68770.b3
10.1212/WNL.56.5.673
10.1093/brain/awh586
10.1093/brain/awh223
10.1136/jnnp.54.8.683
10.1212/01.wnl.0000216271.96364.50
10.1161/01.str.0000129643.77045.10
10.1212/WNL.43.9.1683
10.1212/WNL.51.2.452
10.1161/hyp.38.1.110
10.1056/NEJMoa051469
10.1001/archneur.62.7.1091
10.1086/302698
10.1161/circulationaha.104.501163
10.1161/str.17.6.3810706
10.1038/ng786
10.1161/str.29.6.1177
10.1161/01.str.0000189696.70989.a4
10.1073/pnas.0308679101
10.1161/str.26.7.1293
10.1038/ng1533
10.1007/s004010100439
10.1016/S0140-6736(97)08083-5
10.1161/str.27.8.1274
10.1097/00005072-199709000-00001
10.1161/str.28.3.652
10.1002/ana.410440506
10.1212/WNL.52.7.1361
10.1093/brain/awh023
10.1006/nimg.2002.1040
10.1016/S0021-9150(02)00041-2
10.1161/01.str.0000177867.39769.cb
10.1161/01.hyp.0000112303.26158.92
10.1038/383707a0
10.1016/S0140-6736(95)91557-5
10.1212/WNL.45.5.883
10.1161/01.str.0000131546.71733.f1
10.1007/s004150050398
10.1148/radiol.2293021354
10.1161/hyp.39.2.343
10.1093/brain/awh282
ContentType Journal Article
Copyright 2006 INIST-CNRS
Copyright_xml – notice: 2006 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7TK
8FD
FR3
P64
RC3
7X8
DOI 10.1161/01.STR.0000245084.35575.66
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
Genetics Abstracts
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 2689
ExternalDocumentID 17008614
18266901
10_1161_01_STR_0000245084_35575_66
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
123
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
A9M
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
AAYJJ
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADGHP
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YQJ
YYP
ZB8
ZGI
ZZMQN
IQODW
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OJAPA
OLW
RHF
YCJ
7TK
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c415t-c0eb4c18881bd3961a14861dae4488266a74c67a0e464f75bd1447ce202c34283
ISSN 0039-2499
1524-4628
IngestDate Fri Jul 11 00:43:42 EDT 2025
Fri Jul 11 04:41:26 EDT 2025
Wed Feb 19 01:44:01 EST 2025
Mon Jul 21 09:16:12 EDT 2025
Tue Jul 01 03:03:39 EDT 2025
Thu Apr 24 23:12:01 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Stroke
Nervous system diseases
white matter hyperintensities
Cardiovascular disease
Nuclear magnetic resonance imaging
White matter
Cerebral disorder
Vascular disease
CADASIL
genetics
Central nervous system disease
CADASIL syndrome
Cerebrovascular disease
Hyperintensity
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c415t-c0eb4c18881bd3961a14861dae4488266a74c67a0e464f75bd1447ce202c34283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 17008614
PQID 19359768
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_69021605
proquest_miscellaneous_19359768
pubmed_primary_17008614
pascalfrancis_primary_18266901
crossref_citationtrail_10_1161_01_STR_0000245084_35575_66
crossref_primary_10_1161_01_STR_0000245084_35575_66
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-11-01
PublicationDateYYYYMMDD 2006-11-01
PublicationDate_xml – month: 11
  year: 2006
  text: 2006-11-01
  day: 01
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2006
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
(e_1_3_2_41_2) 2005; 26
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_25_2
(e_1_3_2_33_2) 2006; 27
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
References_xml – ident: e_1_3_2_27_2
  doi: 10.1093/brain/114.2.761
– ident: e_1_3_2_16_2
  doi: 10.1007/s004150050083
– ident: e_1_3_2_34_2
  doi: 10.1161/01.str.0000196987.68770.b3
– ident: e_1_3_2_35_2
  doi: 10.1212/WNL.56.5.673
– ident: e_1_3_2_43_2
  doi: 10.1093/brain/awh586
– ident: e_1_3_2_8_2
  doi: 10.1093/brain/awh223
– ident: e_1_3_2_15_2
  doi: 10.1136/jnnp.54.8.683
– ident: e_1_3_2_10_2
  doi: 10.1212/01.wnl.0000216271.96364.50
– ident: e_1_3_2_22_2
  doi: 10.1161/01.str.0000129643.77045.10
– ident: e_1_3_2_26_2
  doi: 10.1212/WNL.43.9.1683
– ident: e_1_3_2_5_2
  doi: 10.1212/WNL.51.2.452
– ident: e_1_3_2_36_2
  doi: 10.1161/hyp.38.1.110
– ident: e_1_3_2_45_2
  doi: 10.1056/NEJMoa051469
– ident: e_1_3_2_13_2
  doi: 10.1001/archneur.62.7.1091
– ident: e_1_3_2_19_2
  doi: 10.1086/302698
– volume: 27
  start-page: 359
  year: 2006
  ident: e_1_3_2_33_2
  publication-title: AJNR Am J Neuroradiol
– ident: e_1_3_2_40_2
  doi: 10.1161/circulationaha.104.501163
– ident: e_1_3_2_25_2
  doi: 10.1161/str.17.6.3810706
– ident: e_1_3_2_18_2
  doi: 10.1038/ng786
– ident: e_1_3_2_20_2
  doi: 10.1161/str.29.6.1177
– ident: e_1_3_2_9_2
  doi: 10.1161/01.str.0000189696.70989.a4
– ident: e_1_3_2_42_2
  doi: 10.1073/pnas.0308679101
– ident: e_1_3_2_24_2
  doi: 10.1161/str.26.7.1293
– ident: e_1_3_2_44_2
  doi: 10.1038/ng1533
– volume: 26
  start-page: 2481
  year: 2005
  ident: e_1_3_2_41_2
  publication-title: AJNR Am J Neuroradiol
– ident: e_1_3_2_30_2
  doi: 10.1007/s004010100439
– ident: e_1_3_2_12_2
  doi: 10.1016/S0140-6736(97)08083-5
– ident: e_1_3_2_39_2
  doi: 10.1161/str.27.8.1274
– ident: e_1_3_2_29_2
  doi: 10.1097/00005072-199709000-00001
– ident: e_1_3_2_23_2
  doi: 10.1161/str.28.3.652
– ident: e_1_3_2_3_2
  doi: 10.1002/ana.410440506
– ident: e_1_3_2_6_2
  doi: 10.1212/WNL.52.7.1361
– ident: e_1_3_2_31_2
  doi: 10.1093/brain/awh023
– ident: e_1_3_2_17_2
  doi: 10.1006/nimg.2002.1040
– ident: e_1_3_2_32_2
  doi: 10.1016/S0021-9150(02)00041-2
– ident: e_1_3_2_38_2
  doi: 10.1161/01.str.0000177867.39769.cb
– ident: e_1_3_2_21_2
  doi: 10.1161/01.hyp.0000112303.26158.92
– ident: e_1_3_2_1_2
  doi: 10.1038/383707a0
– ident: e_1_3_2_2_2
  doi: 10.1016/S0140-6736(95)91557-5
– ident: e_1_3_2_28_2
  doi: 10.1212/WNL.45.5.883
– ident: e_1_3_2_11_2
  doi: 10.1161/01.str.0000131546.71733.f1
– ident: e_1_3_2_14_2
  doi: 10.1007/s004150050398
– ident: e_1_3_2_7_2
  doi: 10.1148/radiol.2293021354
– ident: e_1_3_2_37_2
  doi: 10.1161/hyp.39.2.343
– ident: e_1_3_2_4_2
  doi: 10.1093/brain/awh282
SSID ssj0002385
Score 2.1379652
Snippet Background and Purpose— The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with...
The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and...
BACKGROUND: and Purpose- The phenotypic expressivity shows striking variability among individuals with CADASIL (cerebral autosomal dominant arteriopathy with...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 2684
SubjectTerms Adult
Biological and medical sciences
Brain - pathology
CADASIL - epidemiology
CADASIL - genetics
CADASIL - pathology
Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes
Female
Humans
Investigative techniques, diagnostic techniques (general aspects)
Magnetic Resonance Imaging
Male
Medical sciences
Middle Aged
Nervous system
Nervous system (semeiology, syndromes)
Neurology
Quantitative Trait, Heritable
Radiodiagnosis. Nmr imagery. Nmr spectrometry
Receptor, Notch3
Receptors, Notch - genetics
Vascular diseases and vascular malformations of the nervous system
Subtitle Evidence for Genetic Modifiers
Title Heritability of MRI Lesion Volume in CADASIL
URI https://www.ncbi.nlm.nih.gov/pubmed/17008614
https://www.proquest.com/docview/19359768
https://www.proquest.com/docview/69021605
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQuM2CmP4gbcpJU4cJ-WtbEAHGxJrJ-0tchxbqtYl0Zpq0n49x5dcNqg0eKmqJHZUf19Ov-OcC0IfuB_SJOIUEFDKo0kOz1weMi_mXMDfbwAaxUT5_mTTM_r9PDofDKpe1NK6zkbi5q95Jf-DKhwDXHWW7D8g204KB-A74AufgDB83gvjqdSuvQlvNS_KT06P9pdS73_tW6tjcvomh5PZ0bFpweNaiJrYQphVJzDqXjgLtXCB8I1OndVX5YWRn2Qc-_3NWF2G4KIrS9Bjlwn1XVl6LVupPi2X9SUvilWl38l_ZrXrBKKThNbtVd_Ayb6WRV67_BsTZ8nv7kmQdk9COjsaUE-nvfYNra3u0hCK9M0ms33i_rTnjJgchdFsfmpKTQYUFCUdgUqKo5Ht19IDuro0SOuagwmzyal3qmk3px6ghwE4FtqU__jV1ZcHARO50rRw64-bb6yLzbqpbimaJxVfwcOlbFeUzW6LkS_zbfTU-R14Ykn0DA1k8Rw9OnGRFS_QcZ9LuFQYuIQtl7BdWLwosOPSJ9wwCQOTsGMSbpn0Ep19_TI_mHqu04YnQMDVnvBlRgVJEnBi8nDMCAcvmZGcS_DewQFlPKaCxdyXlFEVR1kOfngsZOAHItQl-16hraIs5GuEE65YBqo2UiSjlClQQCrLxlpnS8mDfIjGzWqlwpWh191QlqlxRxlJfZLCoqfdoqdm0VPGhihsx1a2GMu9Ru3dAqUbqn8Z6OEhet-glIJx1W_MeCHL9SolOm8dHPLNV8D4gDA_GqIdC283u6PHm41n3qLH3cOzi7bqq7V8BxK3zvYMK38DTlOaTA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Heritability+of+MRI+lesion+volume+in+CADASIL%3A+evidence+for+genetic+modifiers&rft.jtitle=Stroke+%281970%29&rft.au=Opherk%2C+Christian&rft.au=Peters%2C+Nils&rft.au=Holtmannsp%C3%B6tter%2C+Markus&rft.au=Gschwendtner%2C+Andreas&rft.date=2006-11-01&rft.eissn=1524-4628&rft.volume=37&rft.issue=11&rft.spage=2684&rft_id=info:doi/10.1161%2F01.STR.0000245084.35575.66&rft_id=info%3Apmid%2F17008614&rft.externalDocID=17008614
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon